Ding L, Hayes MM, Photenhauer A, Eaton KA, Li Q, Ocadiz-Ruiz R, et al
LX 1001 is in an open-label Phase 1/2 trial of 15 APOE4 homozygous individuals with MCI or mild-to-moderate AD dementia (NCT03634007)
DSIP Peptides DSIP (Delta SleepInducing Peptide) is a naturally occurring neuropeptide commonly incorporated into peptide therapy plans targeting sleep quality, recovery, and nervous system health
Medical supervision helps identify risks before a patient starts combining therapies
Insulin-sensitizing peptides warrant caution given Retatrutides glucose effects
Tirzepatide has also shown some promising results with up to 8% absolute reduction in liver fat content in a RCT